Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro
AUTOR(ES)
Parkkila, Seppo
FONTE
The National Academy of Sciences
RESUMO
Acidification of the extracellular milieu of malignant tumors is reported to increase the invasive behavior of cancer cells. In normal tissues, production of acid is catalyzed by carbonic anhydrases (CAs), some of which are known to be overexpressed in certain cancers. To investigate the functional role of CA activity in such cancer cells, we analyzed the effect of acetazolamide, a potent CA inhibitor, on the invasive capacity of four renal carcinoma cell lines (Caki-1, Caki-2, ACHN, and A-498). We found that 10 μM acetazolamide inhibited the relative invasion rate of these cell lines between 18–74%. The Caki-2 and ACHN cell lines displayed the highest responsiveness, and their responses clearly depended on the acetazolamide concentration in the culture medium. Immunocytochemical and Western blotting results identified the presence of CA isoenzyme II in the cytoplasm of all four cell lines and CA XII on the plasma membrane in three of four cell lines. Because acetazolamide alone reduced invasiveness of these cancer cells in vitro, we conclude that the CAs overexpressed in these renal cancer cells contribute to invasiveness, at least in vitro, and suggest that CA inhibitors may also reduce invasiveness in other tumors that overexpress one or more CAs.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=15781Documentos Relacionados
- THE EFFECT OF A SINGLE ORAL DOSE OF THE CARBONIC ANHYDRASE INHIBITOR, ACETAZOLEAMIDE, IN RENAL DISEASE
- Hyperkalaemia induced by carbonic anhydrase inhibitor.
- Inhibition of carbonic anhydrase by parathyroid hormone and cyclic AMP in rat renal cortex in vitro.
- Effects of a carbonic anhydrase inhibitor on cerebral blood flow in geriatric patients.
- Carbonic anhydrase inhibitors and osmotic agents in glaucoma. Carbonic anhydrase inhibitors.
